KHRC Hosts Delegation From GSK
February 08, 2023 | News | Reading time: 3 min
On February 8, 2023, KHRC hosted a team from GSK, one of the Centre’s key collaborators. As part of their visit to the Centre, the team made a presentation detailing the mission of GSK, its initiative (AmbassadRix project) aimed at understanding vaccine experience in Ghana, the realities and challenges). Following this presentation, KHRC management and staff interacted with them on this initiative particularly focusing on their capacity building initiatives.
Director of KHRC, Dr. Kwaku Poku Asante gave an overview of the history of KHRC and key thematic areas which include clinical trials and intervention, operational and implementation research, communicable and non-communicable diseases, environmental health, malaria and neglected tropical diseases, health policy and programme evaluation and family health research.
Dr. Asante seized the opportunity to reiterate the story about the first malaria vaccine (RTS,S) of which KHRC contributed to its development by conducting the phase 2, phase 3 and phase 4 trials. His presentation also highlighted contributions to Ghana Health Services policy initiatives, opportunities gained, some challenges, among others.
He expressed KHRC's appreciation for GSK's support and contribution to KHRC's clinical trial transformation. He stressed the burgeoning need to build both institutional and human capacity, since this will be needed to advance the conduct of both clinical trials as well as epidemiological studies.
As part of the visit, the GSK team will have the opportunity to tour some basic schools as well as some health facilities to have firsthand experience with the educational and health systems of Ghana.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.